Interpretation of Chinese expert consensus on the surgical treatment for adenocarcinoma of esophagogastric junction(2024 edition)
10.3760/cma.j.cn441530-20231212-00214
- VernacularTitle:食管胃结合部腺癌外科治疗中国专家共识（2024年版）解读
- Author:
Kai LIU
1
,
2
;
Yunfeng ZHU
;
Yushang YANG
;
Longqi CHEN
;
Jiankun HU
Author Information
1. 四川大学华西医院普通外科 胃癌中心&
2. 胃癌研究室，成都 610041
- Keywords:
Adenocarcinoma of esophagogastric junction;
Surgery;
Consensus;
Interpretation
- From:
Chinese Journal of Gastrointestinal Surgery
2024;27(2):127-131
- CountryChina
- Language:Chinese
-
Abstract:
Due to the unique nature of its anatomical location, the adenocarcinoma of esophagogastric junction (AEG) has been a subject of controversy and disagreement including its definition, staging, and treatment strategies. Chinse expert Consensus on Surgical Treatment of Adenocarcinoma of Esophagogastric Junction in China (2018 Edition) had been released in September 2018 and had played a pioneering role in unifying thoracic and general surgeons in China on surgical treatment strategies for AEG. Over the past five years, the emergence of several clinical research results on AEG has provided new clinical evidence for the selection of key surgical treatment strategies. Therefore, to further standardize the surgical treatment of AEG in China, Chinese Expert Consensus on Surgical Treatment of Adenocarcinoma of Esophagogastric Junction in China (2024 Edition) was released in 2024 by Chinese expert panel including 25 gastrointestinal surgeons and 24 thoracic surgeons. Based on the highest-level clinical research evidence in recent 5 years, this consensus ultimately formulates 29 recommendations on hotspots and key points on surgical treatment of AEG and summary 5 issues that are still awaiting further exploration. This review will provide a summary and detailed interpretation of the recommendations outlined in this consensus.
